DCs are concentrated in the BM during MGUS to MM progression and are able to process and cross-present antigens from apoptotic MM cells via CD91, thus activating myeloma-specific CD8+ T cells [73]. This evidence concerns the gene CD8A and Miyoshi myopathy.